Cite
HARVARD Citation
Leclercq, G. et al. (n.d.). 653 Dasatinib as a rapid pharmacological ON/OFF switch for T cell bispecific antibody-induced T cell activation and cytokine release. Journal for immunotherapy of cancer. pp. A391-A392. [Online].